qun: ECSBDAZE- 3A76- AEEB- ssra- 6D1C4BBDSDBF
MA- M—A As-B 1A-PR

IIIIIIIIIIIIIIllllIIIllIIIIIIIIIIIlIIIIIIlIIIIIIII(ad
Ill"‘IIIIIITIIIIIIIIIIIIII||||||||||||||I|||IIIIIIIIIIIIIIIIIIIIIIIIIIII

lllI
IHIIIIIIIIIIIII IIIIIIIIIIIIIIIIIIIII II IlIIIIIIIIIIIlIIIII IIIIII

' Pancreas Cancer

<Slide key: A: pancreatic resection margin, 8' #18, C: LN #14, D: omentum,
E: LN #5, F: LN #8. G: LN #12, H1 LN 13#, I: LN 16#, 1: , 2-5: duodenum

(2: * ampuIIa of vater, 3 ,

6: duodenun 7—8: CBD

9: CBI 0-11: GB (10: CBD opening , 12:

13: ampuIIa of vater

MICRO (25 HE)

DIAGNOSIS:
Head of pancreas, duodenum, common bile duct and gallbladder.
pylorus-preserving pancreaticoduodenectomy:

Ductal adenocarcinoma, well differentiated. pancreas
with 1) tumor size: 3.5x2.30m
2) extension to peripancreatic soft tissue
) invasion to duodenum, common bile duct and ampuIIa of Vater
) perineural invasion, multifocal
) venous invasion: not identified
) clear pancreatic, common bile duct and duodenal resection margins
) metastasis to two out of 22 regional lymph nodes
(LN #13: 0/4, LN #14: 0/1, LN #5: 0/0, LN #8: 0/2, LN #12: 0/11,
LN #16: 0/13. peripancreatic LN: 1/1)
8) pathologic staging: pT3 Nib

3
4
5
6
7

[Cb'0’3

a£h4w1144wa4~wa ciKAJLIIUUS 31750/3
pars (5m.- 3W, no; 695,7
cow= pmwurlkul 89$”
lJﬁO/‘b’

cnm‘u _ j“)
(.c

Primary Tuinm 5n
HIPAA lec:

Case is

 

